Sunshine Biopharma Inc. (SBFM)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug
Sunshine Biopharma Inc. SBFM traded higher on Wednesday, with a session volume of 19.07 million compared to an average volume of 88.16K, according to data from Benzinga Pro.
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
FORT LAUDERDALE, FL / ACCESSWIRE / January 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals is pleased to announce the appointment of Mr. Michel Roy as its new Chief Commercial Officer (CCO), effective immediately.
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
FORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed an orally active protease inhibitor with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2). There are still unmet medical needs for agents to combat SARS-CoV-2 infections.
Sunshine Biopharma Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Christopher C. Powers Farther Finance Advisors, LLC | 0.1 | $3.18 | $0.22 | -$2.96 | -93.08% |
 Kevin Bresler TD Waterhouse Canada Inc. | 0.1 | $3.18 | $0.22 | -$2.96 | -93.08% |
Sunshine Biopharma Inc. (SBFM) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sunshine Biopharma Inc. ever had a stock split?
Sunshine Biopharma Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Steve N. Slilaty CEO | NASDAQ (CM) Exchange | 867781809 CUSIP |
| CA Country | 52 Employees | - Last Dividend | 1 Jun 2026 Last Split | 30 Oct 2009 IPO Date |
Overview
Sunshine Biopharma, Inc. is a New York-based pharmaceutical company devoted to the discovery, development, and commercialization of innovative treatments for various diseases, with a strong focus on oncology and antiviral medications. The company's mission centers on advancing the science of life-saving medicines to address unmet medical needs in several therapeutic areas. Through cutting-edge research and development efforts, Sunshine Biopharma, Inc. aims to bring forward novel solutions capable of combating some of the most challenging diseases, including various forms of cancer and viral infections.
Products and Services
- Adva-27a: This leading compound in development by Sunshine Biopharma is a groundbreaking GEM-difluorinated C-glycoside derivative of podophyllotoxin designed to effectively treat a wide range of cancers such as leukemia, lymphoma, and cancers of the testes, lungs, brain, prostate, bladder, colon, ovaries, liver, and more. Remarkably, Adva-27a is also engineered to eliminate multidrug-resistant cancer cells, covering pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells.
- SBFM-PL4: Sunshine Biopharma is also working on SBFM-PL4, an anti-coronavirus treatment compound. This innovative solution demonstrates the company's flexibility and commitment to addressing emergent global health crises by developing treatments for infectious diseases, such as those caused by coronaviruses.
- K1.1 mRNA molecules: These molecules represent another frontier Sunshine Biopharma is exploring in its battle against cancer. The K1.1 mRNA molecules are under development for use as anti-cancer agents, showcasing the company's dedication to leveraging advanced molecular technology to forge new paths in cancer therapy.
- Essential 9: Beyond its pharmaceutical innovations, Sunshine Biopharma offers Essential 9, a supplement containing nine essential amino acids critical for human health. This product reflects the company’s interest in supporting overall well-being through science-based nutritional supplements.
- Essential Calcium-Vitamin D: This supplement, marketed under the Essential Calcium-Vitamin D brand, is designed to support bone health and calcium absorption. It's part of Sunshine Biopharma’s range of health and wellness products geared towards enhancing the nutritional intake of its customers.
